KRRO · Korro Bio, Inc.
$13.26
-0.42 (-3.07%)
At close · Aug 27
Market Cap
$195.26M
Shares
14.73M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-04 | 2026 Jefferies Global Healthcare Conference | Conference |
| 2026-05-27 | EASL Congress 2026 | Event |
| 2026-05-20 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-05-19 | HCW 4th Annual BioConnect Nasdaq Investor Conference | Conference |
| 2026-05-15 | A GalNAc-conjugated RNA editing oligonucleotide achieves >90% editing of pathogenic SERPINA1 transcripts, restoring Alpha-1 Antitrypsin function in AATD models | Event |
| 2026-05-14 | TIDES USA 2026: Oligonucleotide and Peptide Therapeutics Conference | Conference |
| 2026-05-14 | American Society of Gene and Cell Therapy 29th Annual Meeting (ASGCT) | Shareholder meeting |
| 2026-04-24 | 3rd International Conference on Ureagenesis Defects and Allied Conditions | Conference |
Source: https://ir.korrobio.com/
Key facts
CIK
1703647
CUSIP
500946108
13F (30d)
95 filings
93 filers
Visit website
Investor relations